Literature DB >> 19828746

Pseudomonas aeruginosa genotype prevalence in Dutch cystic fibrosis patients and age dependency of colonization by various P. aeruginosa sequence types.

Rosa van Mansfeld1, Rob Willems, Roland Brimicombe, Harry Heijerman, Ferdinand Teding van Berkhout, Tom Wolfs, Cornelis van der Ent, Marc Bonten.   

Abstract

The patient-to-patient transmission of highly prevalent Pseudomonas aeruginosa clones which are associated with enhanced disease progression has led to strict segregation policies for cystic fibrosis (CF) patients in many countries. However, little is known about the population structure of P. aeruginosa among CF patients. The aim of the present cross-sectional study was to determine the prevalence and genetic relatedness of P. aeruginosa isolates from CF patients who visited two major CF centers in The Netherlands in 2007 and 2008. These patients represented 45% of the Dutch CF population. P. aeruginosa carriage in the respiratory tract was determined by standard microbiological culture techniques, and all phenotypically different isolates in the first specimens recovered in 2007 and 2008 were genotyped by multilocus sequence typing. A total of 313 (57%) of 551 patients whose samples were cultured carried P. aeruginosa. Two sequence types (STs), ST406 and ST497, were found in 15% and 5% of the patients, respectively, and 60% of the patients harbored a strain that was also found in at least two other patients. The risk ratios for carrying ST406 and ST497 were 17.8 (95% confidence interval [CI], 7.2 to 43.6) for those aged between 15 and 24 years and 6 (95% CI, 1.4 to 26.1) for those aged >25 years. ST406 and ST497 were not genetically linked to previously described epidemic clones, which were also not found in this CF population. The population structure of P. aeruginosa in Dutch CF patients is characterized by the presence of two prevalent STs that are associated with certain age groups and that are not genetically linked to previously described epidemic clones.

Entities:  

Mesh:

Year:  2009        PMID: 19828746      PMCID: PMC2786644          DOI: 10.1128/JCM.01462-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms.

Authors:  H Grundmann; S Hori; G Tanner
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 2.  Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

Authors:  G Döring; S P Conway; H G Heijerman; M E Hodson; N Høiby; A Smyth; D J Touw
Journal:  Eur Respir J       Date:  2000-10       Impact factor: 16.671

3.  Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.

Authors:  J L Burns; R L Gibson; S McNamara; D Yim; J Emerson; M Rosenfeld; P Hiatt; K McCoy; R Castile; A L Smith; B W Ramsey
Journal:  J Infect Dis       Date:  2000-12-27       Impact factor: 5.226

4.  Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa.

Authors:  S J McCallum; J Corkill; M Gallagher; M J Ledson; C A Hart; M J Walshaw
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

5.  Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.

Authors:  A M Jones; J R Govan; C J Doherty; M E Dodd; B J Isalska; T N Stanbridge; A K Webb
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

6.  Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.

Authors:  C K Stover; X Q Pham; A L Erwin; S D Mizoguchi; P Warrener; M J Hickey; F S Brinkman; W O Hufnagle; D J Kowalik; M Lagrou; R L Garber; L Goltry; E Tolentino; S Westbrock-Wadman; Y Yuan; L L Brody; S N Coulter; K R Folger; A Kas; K Larbig; R Lim; K Smith; D Spencer; G K Wong; Z Wu; I T Paulsen; J Reizer; M H Saier; R E Hancock; S Lory; M V Olson
Journal:  Nature       Date:  2000-08-31       Impact factor: 49.962

7.  Pseudomonas aeruginosa in cystic fibrosis: cross-infection and the need for segregation.

Authors:  D Tubbs; W Lenney; P Alcock; C A Campbell; J Gray; C Pantin
Journal:  Respir Med       Date:  2001-02       Impact factor: 3.415

8.  Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients.

Authors:  G Fluge; B Ojeniyi; N Høiby; A Digranes; O Ciofu; E Hunstad; O C Haanaes; O T Storrøsten
Journal:  Clin Microbiol Infect       Date:  2001-05       Impact factor: 8.067

9.  Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic.

Authors:  David S Armstrong; Gillian M Nixon; Rosemary Carzino; Andrea Bigham; John B Carlin; Roy M Robins-Browne; Keith Grimwood
Journal:  Am J Respir Crit Care Med       Date:  2002-10-01       Impact factor: 21.405

10.  Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.

Authors:  David P Speert; Maureen E Campbell; Deborah A Henry; Ruth Milner; Fatma Taha; Anna Gravelle; A George F Davidson; Lawrence T K Wong; Eshwar Mahenthiralingam
Journal:  Am J Respir Crit Care Med       Date:  2002-10-01       Impact factor: 21.405

View more
  23 in total

1.  Emergence of a mutL mutation causing multilocus sequence typing-pulsed-field gel electrophoresis discrepancy among Pseudomonas aeruginosa isolates from a cystic fibrosis patient.

Authors:  María García-Castillo; Luis Máiz; María-Isabel Morosini; Mercedes Rodríguez-Baños; Lucrecia Suarez; Ana Fernández-Olmos; Fernando Baquero; Rafael Cantón; Rosa del Campo
Journal:  J Clin Microbiol       Date:  2012-02-08       Impact factor: 5.948

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Evaluation of the DiversiLab system for detection of hospital outbreaks of infections by different bacterial species.

Authors:  A C Fluit; A M Terlingen; L Andriessen; R Ikawaty; R van Mansfeld; J Top; J W Cohen Stuart; M A Leverstein-van Hall; C H E Boel
Journal:  J Clin Microbiol       Date:  2010-09-22       Impact factor: 5.948

Review 4.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

5.  Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis.

Authors:  Timothy J Kidd; Keith Grimwood; Kay A Ramsay; Paul B Rainey; Scott C Bell
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

6.  Molecular Characterization and Phylogenetic Analysis of Pseudomonas aeruginosa Isolates Recovered from Greek Aquatic Habitats Implementing the Double-Locus Sequence Typing Scheme.

Authors:  Olga Pappa; Apostolos Beloukas; Apostolos Vantarakis; Athena Mavridou; Anastasia-Maria Kefala; Alex Galanis
Journal:  Microb Ecol       Date:  2016-12-28       Impact factor: 4.552

7.  Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals.

Authors:  María García-Castillo; Rosa Del Campo; María Isabel Morosini; Elena Riera; Gabriel Cabot; Rob Willems; Rosa van Mansfeld; Antonio Oliver; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

8.  Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types.

Authors:  Pascal Cholley; Michelle Thouverez; Didier Hocquet; Nathalie van der Mee-Marquet; Daniel Talon; Xavier Bertrand
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

9.  Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study.

Authors:  Damien Fournier; Romain Carrière; Maxime Bour; Emilie Grisot; Pauline Triponney; Cédric Muller; Jérôme Lemoine; Katy Jeannot; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

10.  Tracking down antibiotic-resistant Pseudomonas aeruginosa isolates in a wastewater network.

Authors:  Céline Slekovec; Julie Plantin; Pascal Cholley; Michelle Thouverez; Daniel Talon; Xavier Bertrand; Didier Hocquet
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.